Emanuele Varaldo, Francesca Rumbolo, Nunzia Prencipe, Fabio Bioletto, Fabio Settanni, Giulio Mengozzi, Silvia Grottoli, Ezio Ghigo, Luca Brazzi, Giorgia Montrucchio, Alessandro Maria Berton
Objective: To investigate whether copeptin, MR-proADM and MR-proANP, alone or integrated with the SOFA, MuLBSTA and SAPS II scores, are capable of early recognition of COVID-19 ICU patients at increased risk of adverse outcomes. Methods: For this predefined secondary analysis of a larger cohort previously described, all consecutive COVID-19 adult patients admitted between March and December 2020 to the ICU of a referral, university hospital in Northern Italy were screened, and clinical severity scores were calculated upon admission...
March 30, 2024: Journal of Clinical Medicine